Deep Track Capital as of Dec. 31, 2025
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 55 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Series Trust State Street Spd Put Option (XBI) | 21.7 | $1.2B | 10M | 121.93 | |
| Immunovant (IMVT) | 5.2 | $293M | 12M | 25.42 | |
| Guardant Health (GH) | 5.1 | $286M | 2.8M | 102.14 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 5.1 | $286M | 4.1M | 69.55 | |
| Tarsus Pharmaceuticals (TARS) | 4.4 | $246M | 3.0M | 81.88 | |
| Dynavax Technologies Corp Com New (DVAX) | 4.3 | $242M | 16M | 15.38 | |
| Cytokinetics Com New (CYTK) | 3.8 | $212M | 3.3M | 63.54 | |
| Axsome Therapeutics (AXSM) | 3.7 | $210M | 1.2M | 182.64 | |
| Apellis Pharmaceuticals (APLS) | 3.5 | $195M | 7.8M | 25.12 | |
| Vaxcyte (PCVX) | 3.3 | $185M | 4.0M | 46.14 | |
| Maze Therapeatics (MAZE) | 3.1 | $176M | 4.2M | 41.43 | |
| Vera Therapeutics Cl A (VERA) | 2.5 | $143M | 2.8M | 50.64 | |
| BioMarin Pharmaceutical (BMRN) | 2.4 | $137M | 2.3M | 59.43 | |
| Ionis Pharmaceuticals (IONS) | 2.4 | $135M | 1.7M | 79.11 | |
| Nurix Therapeutics (NRIX) | 2.4 | $134M | 7.0M | 18.97 | |
| Mbx Biosciences (MBX) | 1.8 | $103M | 3.2M | 31.54 | |
| Ocular Therapeutix (OCUL) | 1.7 | $98M | 8.1M | 12.14 | |
| Grail (GRAL) | 1.6 | $88M | 1.0M | 85.59 | |
| Miragen Therapeutics (VRDN) | 1.4 | $79M | 2.5M | 31.12 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 1.3 | $75M | 3.4M | 22.26 | |
| Immunocore Hldgs Ads (IMCR) | 1.2 | $70M | 2.0M | 34.71 | |
| Oruka Therapeutics (ORKA) | 1.2 | $66M | 2.2M | 30.31 | |
| Bridgebio Pharma (BBIO) | 1.1 | $62M | 810k | 76.49 | |
| Cormedix Inc cormedix (CRMD) | 1.1 | $61M | 5.3M | 11.63 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.1 | $61M | 4.6M | 13.18 | |
| Alkermes SHS (ALKS) | 1.0 | $56M | 2.0M | 27.98 | |
| Dyne Therapeutics (DYN) | 0.9 | $52M | 2.7M | 19.56 | |
| Celldex Therapeutics Com New (CLDX) | 0.9 | $52M | 1.9M | 27.16 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.9 | $51M | 7.3M | 6.90 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.9 | $50M | 2.0M | 25.01 | |
| Soleno Therapeutics (SLNO) | 0.8 | $46M | 1.0M | 46.30 | |
| Verastem Com New (VSTM) | 0.8 | $44M | 5.7M | 7.72 | |
| Bicara Therapeutics (BCAX) | 0.8 | $44M | 2.6M | 16.83 | |
| Geron Corporation (GERN) | 0.8 | $43M | 33M | 1.32 | |
| Engene Holdings (ENGN) | 0.7 | $40M | 4.4M | 9.03 | |
| Biosante Pharmaceuticals (ANIP) | 0.7 | $38M | 478k | 78.94 | |
| Terns Pharmaceuticals (TERN) | 0.6 | $31M | 769k | 40.40 | |
| Enanta Pharmaceuticals (ENTA) | 0.6 | $31M | 2.0M | 15.77 | |
| Mind Medicine Mindmed Com New (MNMD) | 0.4 | $22M | 1.7M | 13.39 | |
| Tango Therapeutics (TNGX) | 0.4 | $22M | 2.5M | 8.86 | |
| X4 Pharmaceuticals Com New (XFOR) | 0.4 | $20M | 5.0M | 4.00 | |
| Atai Beckley Nv SHS | 0.3 | $19M | 4.7M | 4.09 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $16M | 366k | 44.82 | |
| Cogent Biosciences (COGT) | 0.3 | $16M | 453k | 35.52 | |
| Cybin Com New (HELP) | 0.3 | $15M | 1.9M | 8.18 | |
| Context Therapeutics (CNTX) | 0.2 | $11M | 7.4M | 1.47 | |
| Monopar Therapeutics Com New (MNPR) | 0.1 | $6.2M | 95k | 65.30 | |
| Biohaven Call Option (BHVN) | 0.1 | $5.6M | 500k | 11.29 | |
| Crescent Biopharma (CBIO) | 0.1 | $5.4M | 454k | 11.86 | |
| Aligos Therapeutics Com New (ALGS) | 0.1 | $4.1M | 444k | 9.32 | |
| Billiontoone Cl A (BLLN) | 0.1 | $4.1M | 50k | 81.84 | |
| Rapt Therapeutics Com New (RAPT) | 0.1 | $3.7M | 110k | 33.87 | |
| Inventiva Sa Ads (IVA) | 0.0 | $2.3M | 490k | 4.65 | |
| Janux Therapeutics (JANX) | 0.0 | $1.2M | 90k | 13.80 | |
| Adlai Nortye Sponsored Ads (ANL) | 0.0 | $50k | 35k | 1.42 |
